U.S. Pharmaceuticals & Biotech Top Stock Picks from Analysts

Tevogen Bio Holdings

Market Cap: US$153.3m

A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.

Cybin

Market Cap: US$153.2m

A clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

Nuvectis Pharma

Market Cap: US$152.9m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

Compugen

Market Cap: US$152.5m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Greenwich LifeSciences

Market Cap: US$148.7m

A clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania.

Cardiff Oncology

Market Cap: US$145.7m

A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.

Fate Therapeutics

Market Cap: US$139.5m

A clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally.

Skye Bioscience

Market Cap: US$139.1m

A clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases.

Oncolytics Biotech

Market Cap: US$138.5m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

Cognition Therapeutics

Market Cap: US$136.7m

A clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.

biote

Market Cap: US$136.6m

Operates in practice-building business within the hormone optimization space.

Applied Therapeutics

Market Cap: US$134.5m

A clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States.

Climb Bio

Market Cap: US$134.2m

A clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases.

Kalaris Therapeutics

Market Cap: US$132.6m

A clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases.

Anika Therapeutics

Market Cap: US$131.5m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Ovid Therapeutics

Market Cap: US$130.8m

A biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States.

Atossa Therapeutics

Market Cap: US$130.5m

Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.

TuHURA Biosciences

Market Cap: US$130.1m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

Inovio Pharmaceuticals

Market Cap: US$129.1m

A biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.

Biomea Fusion

Market Cap: US$127.9m

A clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic diseases in the United States.

Agenus

Market Cap: US$125.5m

A clinical-stage biotechnology company, discovers and develops therapies to activate the body's immune system against cancer and infections in the United States and internationally.

TScan Therapeutics

Market Cap: US$123.7m

A clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States.

Inhibikase Therapeutics

Market Cap: US$122.2m

Operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson’s disease and related disorders.

Instil Bio

Market Cap: US$122.2m

A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.

Alpha Cognition

Market Cap: US$120.2m

A biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.

Zentalis Pharmaceuticals

Market Cap: US$119.7m

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States.

Alto Neuroscience

Market Cap: US$119.4m

Operates as a clinical-stage biopharmaceutical company in the United States.

Opus Genetics

Market Cap: US$118.5m

A clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs).

Surrozen

Market Cap: US$118.0m

A biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair.

Spero Therapeutics

Market Cap: US$114.2m

A clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States.

Armata Pharmaceuticals

Market Cap: US$111.2m

Operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.

Adverum Biotechnologies

Market Cap: US$110.6m

A clinical-stage company, develops gene therapy product candidates to treat ocular diseases.

Vistagen Therapeutics

Market Cap: US$110.4m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders.

Nautilus Biotechnology

Market Cap: US$109.8m

A development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.

MacroGenics

Market Cap: US$108.1m

A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.

Anixa Biosciences

Market Cap: US$107.6m

A biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology.